Aptose Biosciences Inc [NASDAQ: APTO] gained 3.33% on the last trading session, reaching $0.21 price per share at the time.
If compared to the average trading volume of 6.69M shares, APTO reached a trading volume of 261107 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Aptose Biosciences Inc [APTO]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for APTO shares is $2.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on APTO stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Cantor Fitzgerald have made an estimate for Aptose Biosciences Inc shares, keeping their opinion on the stock as Overweight, with their previous recommendation back on October 19, 2020. While these analysts kept the previous recommendation, Alliance Global Partners raised their target price to Buy. The new note on the price target was released on September 22, 2020, representing the official price target for Aptose Biosciences Inc stock. Previously, the target price had yet another raise to $16, while Maxim Group analysts kept a Buy rating on APTO stock. On February 06, 2020, analysts increased their price target for APTO shares from 6 to 9.
Trading performance analysis for APTO stock
Aptose Biosciences Inc [APTO] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -2.77. With this latest performance, APTO shares gained by 13.05% in over the last four-week period, additionally sinking by -67.34% over the last 6 months – not to mention a drop of -90.28% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for APTO stock in for the last two-week period is set at 45.51, with the RSI for the last a single of trading hit 46.78, and the three-weeks RSI is set at 43.79 for Aptose Biosciences Inc [APTO]. The present Moving Average for the last 50 days of trading for this stock 0.2472, while it was recorded at 0.2083 for the last single week of trading, and 0.6120 for the last 200 days.
Aptose Biosciences Inc [APTO]: A deeper dive into fundamental analysis
Aptose Biosciences Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.05 and a Current Ratio set at 1.05.
An analysis of Institutional ownership at Aptose Biosciences Inc [APTO]
There are presently around $5.41%, or 5.76%% of APTO stock, in the hands of institutional investors.
